Cohance Lifesciences Complete Financial Statements

COHANCE • Review detailed financials to uncover trends, confirm thesis & journal trades
7 Years of Data
2025 - 2019

Complete Financial Data Export

Export complete financial statements for Cohance Lifesciences (COHANCE). Downloads include all available records across all periods. For market performance, see the COHANCE stock price today .

Profitability Ratios

Net Profit Margin 11.56% 2025 data
EBITDA Margin 23.99% 2025 data
Operating Margin 22.00% 2025 data
Return on Assets 2.18% 2025 data
Return on Equity 3.59% 2025 data

Balance Sheet Ratios

Current Ratio 1.08 2025 data
Debt to Equity 1.65 2025 data
Equity Ratio 60.72% 2025 data
Asset Turnover 0.19 2025 data

Year-over-Year Growth Analysis

Comparing Sept 2024 vs Sept 2025
Revenue Growth
-7.9%
Year-over-Year
Net Profit Growth
-52.2%
Year-over-Year
EBITDA Growth
-38.3%
Year-over-Year
Expense Growth
+9.3%
Year-over-Year
Assets Growth
+34.5%
Year-over-Year
Equity Growth
-10.2%
Year-over-Year
Liabilities Growth
+34.5%
Year-over-Year
Operating Cash Flow Growth
-19.8%
Year-over-Year
Investing Cash Flow Growth
+30.1%
Year-over-Year
Financing Cash Flow Growth
+121.4%
Year-over-Year

Income Statement

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Mar 2021 Jun 2021 Dec 2021 Sept 2020 Mar 2020 Jun 2020 Dec 2020 Sept 2019 Mar 2019 Jun 2019 Dec 2019
Revenue 571 853 564 620 270 508 323 251 381 358 234 289 381 350 367 324 281 293 456 247 211 254 296 282 251 217 190
Expenses 435 627 445 398 180 363 189 133 198 181 154 179 207 188 207 179 166 149 206 140 108 126 138 147 129 95 99
EBITDA 137 226 118 222 90 145 133 118 183 178 80 111 174 162 160 144 116 144 251 107 103 128 158 135 122 122 91
Operating Profit Margin % 22.00% 25.00% 19.00% 34.00% 29.00% 26.00% 38.00% 42.00% 47.00% 48.00% 30.00% 36.00% 43.00% 45.00% 41.00% 40.00% 36.00% 43.00% 48.00% 41.00% 41.00% 47.00% 50.00% 46.00% 49.00% 52.00% 45.00%
Depreciation 44 54 45 38 17 31 20 12 12 13 13 12 10 12 12 9 8 9 11 8 7 7 9 6 6 6 6
Interest 9 10 10 10 2 10 3 1 5 1 2 0 2 2 1 1 2 2 1 3 7 3 2 4 2 4 8
Profit Before Tax 84 161 63 174 71 103 110 105 166 164 66 99 161 149 146 134 106 133 240 97 89 118 148 125 115 113 78
Tax 17 44 16 36 18 28 26 26 42 43 19 26 70 41 38 37 22 28 79 23 15 26 34 32 40 21 20
Net Profit 66 117 46 138 53 75 83 80 124 121 47 72 92 108 108 97 83 105 160 74 74 92 114 93 75 92 58
Earnings Per Share (₹) 1.94 3.16 1.28 3.63 2.10 1.98 3.26 3.13 4.87 4.74 1.84 2.83 3.60 4.22 4.23 3.81 3.27 4.13 6.29 2.91 5.83 3.60 4.46 3.65 5.88 7.22 4.55

Related Pages for Cohance Lifesciences

Additional stock information and data for COHANCE

COHANCE value investing
COHANCE earnings
Cohance Lifesciences stock price data download
COHANCE P/B ratio
COHANCE market cap trends
Cohance Lifesciences share price chart
Cohance Lifesciences yearly highs lows

Balance Sheet

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019
ASSETS
Total Assets 3,032 2,254 1,966 1,830 1,475 1,173 783
Current Assets 889 1,263 1,011 1,128 565 392 390
Fixed Assets 1,713 670 663 534 441 357 271
Capital Work in Progress 256 179 165 30 96 102 111
Investments 337 905 536 598 542 338 7
Other Assets 726 501 601 667 395 376 394
LIABILITIES
Total Liabilities 3,032 2,254 1,966 1,830 1,475 1,173 783
Current Liabilities 826 97 72 92 74 128 35
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 1,841 2,051 1,735 1,527 1,181 845 590
Share Capital 26 26 26 26 26 13 13
Reserves & Surplus 1,671 2,025 1,710 1,502 1,155 832 578

Cash Flow Statement

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019
Operating Activities 288 359 457 330 383 407 50
Investing Activities -253 -362 -195 -136 -311 -414 -66
Financing Activities 3 -14 -242 -156 -76 7 26
Net Cash Flow 38 -18 20 37 -5 1 11